Microarray-Based Cytogenetic Testing Illuminates Congenital Abnormalities, Cancer

Trilochan Sahoo, M.D. is an expert in the development, evaluation, and implementation of microarray-based cytogenomic technologies. A medical doctor by training, his interest in human genetics began early on in his career during his post-doctoral fellowship at Duke University. “My research was focused on identifying the cause of a group of Mendelian genetic disorders,” Dr. Sahoo said. “I moved to Baylor College of Medicine for a clinical cytogenetics fellowship, an area that was on the verge of becoming empowered by genomic analysis tools. I was very fortunate to work with some of the leaders of human genetics at Duke and Baylor. I have not regretted giving up clinical medicine to dive into molecular cytogenetics and human genetics.”